Diary of a Private Investor

Bioventix

Let the madness begin!

The kids go back to school, the grown-ups go back to work and first half results season all begin in earnest next week. On an individual stock level I am happy with the positioning of my largest holdings and on a portfolio level I am broadly happy with the balance and diversification (there is clear […]

, , , , , , , , , , , , , , , , , , , ,

Rebalancing Update Q3 2017

In my posts of 23 June and 1 July, I outlined the rationale for taking an overweight position in IQE and how I planned to mitigate that risk by flattening and broadening the remainder of the portfolio; adding more income and more conservatism, as measured by both volatility and market capitalisation. The main phase of […]

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Two keepers and the one that got away

Happy Friday everyone! Without wishing to tempt fate while there are still a few hours trading to go before markets close but this week looks set to deliver my largest portfolio gain of the year so far. Sometimes market exuberance can be a wonderful thing so long as one is able to find a chair […]

, , , , , ,

Q2 Rebalancing Update

In my last article I highlighted some rebalancing I had planned for my portfolio, including dividend reinvestment. This brief article provides an update on those changes along with commentary: Bioventix (BVXP) – top sliced. This remains my largest holding but I felt it prudent to top slice in order to lock in some of the […]

, , , , , , , , , , , , , , , , , , , , , , , , , ,

Making Hay While The Sun Shines – Q1 2017 Portfolio Review

The Headlines – Overall, my portfolio is up by 11.51% since the start of 2017 (including reinvested dividends) – I currently have 32 holdings of which 22 are profitable positions and 10 are running at a loss, year-to-date (excluding dividends) – A total of 116 trades during the quarter. However, this is a little misleading […]

, , , , , , , , , , , , , , , , , , , , , , , , , ,

Six of the Best Growth Shares in 2017

Continuing this seasonal “Six of the Best” series, today I’ll be sharing my favourite growth shares for the year ahead. Every growth share is only a profit warning away from becoming an investment dog of course and no more so is this the case than with smallcaps. At the same time, smallcaps also provide an […]

, , , , , , , , , , , ,

Three strikes in my portfolio and a great offer from Research Tree

Those 7am RNS announcements can be nerve racking until you have seen whether one of your holdings is announcing good or bad news. This morning I thought I had hit the jackpot when three of my holdings announced excellent news: Bioventix (BVXP) announced final results today for the year ended 30th June 2016 – highlights: […]

, , , , , , , , , ,

Share Watch: Bioventix (BVXP)

The folks at ShareSoc very kindly recorded the presentation made by Peter Harrison, CEO Bioventix, at their Richmond Supper this week. It is a very useful presentation for investors wanting to learn more about the BVXP business model, the predictability of their income streams and how they manage to achieve this without patent protection. BVXP […]

, , ,

Previous Posts